Breaking News, Collaborations & Alliances

CordenPharma, pHLIP Partner on RNA & Gene Therapies

Aims to develop and manufacture small molecule drug payloads directly conjugated with (pHLIP) peptides.

CordenPharma International and pHLIP, Inc. entered into a strategic collaboration to develop and commercialize the pHLIP-LNP targeted delivery platform for RNA-based and genetic therapeutics. The alliance combines CordenPharma’s Lipid NanoParticle (LNP) technology and GMP manufacturing expertise with pHLIP’s pH (Low) Insertion Peptide (pHLIP) targeted delivery technology and drug development expertise to formulate (pHLIP) coated LNPs for use by biopharmaceutical companies seeking to deliver mRNA...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters